Edward J. Rebar

22.1k total citations · 7 hit papers
77 papers, 13.3k citations indexed

About

Edward J. Rebar is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Edward J. Rebar has authored 77 papers receiving a total of 13.3k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Molecular Biology, 18 papers in Genetics and 13 papers in Oncology. Recurrent topics in Edward J. Rebar's work include CRISPR and Genetic Engineering (49 papers), Virus-based gene therapy research (13 papers) and RNA Interference and Gene Delivery (12 papers). Edward J. Rebar is often cited by papers focused on CRISPR and Genetic Engineering (49 papers), Virus-based gene therapy research (13 papers) and RNA Interference and Gene Delivery (12 papers). Edward J. Rebar collaborates with scholars based in United States, United Kingdom and France. Edward J. Rebar's co-authors include Philip D. Gregory, Fyodor D. Urnov, Michael C. Holmes, Jeffrey C. Miller, H. Steve Zhang, Carl O. Pabo, Xiangdong Meng, Dmitry Guschin, George E. Katibah and Gregory J. Cost and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Edward J. Rebar

76 papers receiving 12.9k citations

Hit Papers

Genome editing with engin... 2007 2026 2013 2019 2010 2010 2011 2009 2007 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Genome editing with engineered zinc finger nucleases
    2010 1.6k citations Fyodor D. Urnov, Edward J. Rebar et al. profile →
  2. A TALE nuclease architecture for efficient genome editing
    2010 1.6k citations Jeffrey C. Miller, Siyuan Tan et al. Nature Biotechnology profile →
  3. Genetic engineering of human pluripotent cells using TALE nucleases
    2011 894 citations Dirk Hockemeyer, Haoyi Wang et al. Nature Biotechnology profile →
  4. Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases
    2009 810 citations Dirk Hockemeyer, Frank Soldner et al. Nature Biotechnology profile →
  5. An improved zinc-finger nuclease architecture for highly specific genome editing
    2007 804 citations Jeffrey C. Miller, Michael C. Holmes et al. Nature Biotechnology profile →
  6. Heritable targeted gene disruption in zebrafish using designed zinc-finger nucleases
    2008 681 citations Yannick Doyon, Jasmine M. McCammon et al. Nature Biotechnology profile →
  7. Generation of Isogenic Pluripotent Stem Cells Differing Exclusively at Two Early Onset Parkinson Point Mutations
    2011 555 citations Frank Soldner, Josée Laganière et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edward J. Rebar United States 40 11.7k 3.6k 1.4k 1.3k 630 77 13.3k
Fyodor D. Urnov United States 39 11.6k 1.0× 3.6k 1.0× 832 0.6× 1.4k 1.1× 646 1.0× 84 13.4k
Matthew H. Porteus United States 56 12.3k 1.1× 4.4k 1.2× 1.6k 1.2× 891 0.7× 443 0.7× 165 14.4k
Prashant Mali United States 40 16.4k 1.4× 3.3k 0.9× 888 0.6× 1.4k 1.1× 614 1.0× 96 17.8k
Ophir Shalem United States 21 11.6k 1.0× 2.3k 0.6× 1.1k 0.8× 935 0.7× 341 0.5× 42 13.1k
Vineeta Agarwala United States 10 10.0k 0.9× 2.2k 0.6× 976 0.7× 896 0.7× 422 0.7× 18 12.0k
Michael C. Holmes United States 45 12.5k 1.1× 5.3k 1.5× 2.4k 1.7× 1.2k 0.9× 524 0.8× 104 14.7k
Gregory E. Crawford United States 56 13.8k 1.2× 3.4k 0.9× 801 0.6× 1.5k 1.1× 503 0.8× 120 16.2k
Shengdar Q. Tsai United States 37 12.6k 1.1× 3.1k 0.9× 726 0.5× 1.4k 1.1× 287 0.5× 65 14.1k
Philip D. Gregory United States 61 18.6k 1.6× 6.7k 1.8× 2.6k 1.8× 1.9k 1.5× 800 1.3× 138 21.9k
Albert W. Cheng United States 34 11.4k 1.0× 3.0k 0.8× 490 0.3× 684 0.5× 593 0.9× 51 13.0k

Countries citing papers authored by Edward J. Rebar

Since Specialization
Citations

This map shows the geographic impact of Edward J. Rebar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward J. Rebar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward J. Rebar more than expected).

Fields of papers citing papers by Edward J. Rebar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward J. Rebar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward J. Rebar. The network helps show where Edward J. Rebar may publish in the future.

Co-authorship network of co-authors of Edward J. Rebar

This figure shows the co-authorship network connecting the top 25 collaborators of Edward J. Rebar. A scholar is included among the top collaborators of Edward J. Rebar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward J. Rebar. Edward J. Rebar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Xiaomeng, Mo A. Dao, Kathy White, et al.. (2021). Engineered Hypoimmune Allogeneic CAR T Cells Exhibit Innate and Adaptive Immune Evasion Even after Sensitization in Humanized Mice and Retain Potent Anti-Tumor Activity. Blood. 138(Supplement 1). 1690–1690. 3 indexed citations
2.
Miller, Jeffrey C., Deepak P. Patil, Danny F. Xia, et al.. (2019). Enhancing gene editing specificity by attenuating DNA cleavage kinetics. Nature Biotechnology. 37(8). 945–952. 40 indexed citations
3.
Gammage, Payam A., Carlo Viscomi, Marie‐Lune Simard, et al.. (2018). Genome editing in mitochondria corrects a pathogenic mtDNA mutation in vivo. Nature Medicine. 24(11). 1691–1695. 223 indexed citations
4.
Holmes, Michael C., Andreas Reik, Edward J. Rebar, et al.. (2017). A Potential Therapy for Beta-Thalassemia (ST-400) and Sickle Cell Disease (BIVV003). Blood. 130. 2066–2066. 10 indexed citations
5.
Lillico, Simon, Chris Proudfoot, Tim King, et al.. (2016). Mammalian interspecies substitution of immune modulatory alleles by genome editing. Scientific Reports. 6(1). 21645–21645. 84 indexed citations
6.
Torikai, Hiroki, Tiejuan Mi, Loren Gragert, et al.. (2016). Genetic editing of HLA expression in hematopoietic stem cells to broaden their human application. Scientific Reports. 6(1). 21757–21757. 38 indexed citations
7.
Urnov, Fyodor D., Andreas Reik, Jeff Vierstra, et al.. (2015). Clinical-Scale Genome Editing of the Human BCL11A Erythroid Enhancer for Treatment of the Hemoglobinopathies. Blood. 126(23). 204–204. 9 indexed citations
8.
Torikai, Hiroki, Andreas Reik, Yuanyue Zhou, et al.. (2012). A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR. Blood. 119(24). 5697–5705. 417 indexed citations
9.
Wood, Andrew J., Te‐Wen Lo, Bryan Zeitler, et al.. (2011). Targeted Genome Editing Across Species Using ZFNs and TALENs. Science. 333(6040). 307–307. 499 indexed citations
10.
Soldner, Frank, Josée Laganière, Albert Cheng, et al.. (2011). Generation of Isogenic Pluripotent Stem Cells Differing Exclusively at Two Early Onset Parkinson Point Mutations. Cell. 146(2). 318–331. 555 indexed citations breakdown →
11.
Hockemeyer, Dirk, Haoyi Wang, Samira Kiani, et al.. (2011). Genetic engineering of human ES and iPS cells using TALE nucleases. DSpace@MIT (Massachusetts Institute of Technology). 1 indexed citations
12.
Simsek, Deniz, Erika Brunet, Sunnie Wong, et al.. (2011). DNA Ligase III Promotes Alternative Nonhomologous End-Joining during Chromosomal Translocation Formation. PLoS Genetics. 7(6). e1002080–e1002080. 237 indexed citations
13.
Söldner, F., Josée Laganière, Albert Cheng, et al.. (2011). Generation of Isogenic Pluripotent Stem Cells Differing Exclusively at Two Early Onset Parkinson Point Mutations. Cell. 146(4). 659–659. 21 indexed citations
14.
Guschin, Dmitry, Adam James Waite, George E. Katibah, et al.. (2010). A Rapid and General Assay for Monitoring Endogenous Gene Modification. Methods in molecular biology. 649. 247–256. 406 indexed citations
15.
Cost, Gregory J., Yolanda Santiago, Jeffrey C. Miller, et al.. (2009). BAK and BAX deletion using zinc‐finger nucleases yields apoptosis‐resistant CHO cells. Biotechnology and Bioengineering. 105(2). 330–340. 120 indexed citations
16.
Santiago, Yolanda, Edmond M. Chan, Peiqi Liu, et al.. (2008). Targeted gene knockout in mammalian cells by using engineered zinc-finger nucleases. Proceedings of the National Academy of Sciences. 105(15). 5809–5814. 274 indexed citations
17.
Doyon, Yannick, Jasmine M. McCammon, Jeffrey C. Miller, et al.. (2008). Heritable targeted gene disruption in zebrafish using designed zinc-finger nucleases. Nature Biotechnology. 26(6). 702–708. 681 indexed citations breakdown →
18.
Pérez, Elena, Yann Jouvenot, Jeffrey C. Miller, et al.. (2006). 758. Towards Gene Knock out Therapy for AIDS/HIV: Targeted Disruption of CCR5 Using Engineered Zinc Finger Protein Nucleases (ZFNs). Molecular Therapy. 13. S293–S293. 3 indexed citations
19.
Holmes‐Davis, Rachel, Guofu Li, Andrew C. Jamieson, et al.. (2005). Gene regulation in planta by plant-derived engineered zinc finger protein transcription factors. Plant Molecular Biology. 57(3). 411–423. 16 indexed citations
20.
Ren, Delin, Trevor N. Collingwood, Edward J. Rebar, Alan P. Wolffe, & Heidi S. Camp. (2002). PPARγ knockdown by engineered transcription factors: exogenous PPARγ2 but not PPARγ1 reactivates adipogenesis. Genes & Development. 16(1). 27–32. 307 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fyodor D. Urnov Breakdown of academic impact, for papers by Matthew H. Porteus Breakdown of academic impact, for papers by Prashant Mali Breakdown of academic impact, for papers by Ophir Shalem Breakdown of academic impact, for papers by Vineeta Agarwala Breakdown of academic impact, for papers by Michael C. Holmes Breakdown of academic impact, for papers by Gregory E. Crawford Breakdown of academic impact, for papers by Shengdar Q. Tsai Breakdown of academic impact, for papers by Philip D. Gregory Breakdown of academic impact, for papers by Albert W. Cheng
Rankless by CCL
2026